創傷ケア市場 – 2030年までの世界予測

本レポートは、製品、創傷の種類、エンドユーザー、および国別に創傷ケア市場を分析しています。また、市場の成長に影響を与える要因（推進要因、制約要因、機会、課題など）を分析するとともに、市場リーダーの競争環境の詳細を提供しています。さらに、ミクロ市場を個々の成長傾向の観点から分析しています。さらに、5つの主要地域（および各地域に属する国）における市場セグメントの収益予測も提供しています。

世界の創傷ケア市場は、予測期間中に6.5%のCAGRで成長し、2025年の222.2億米ドルから2030年には304.8億米ドルに達すると予測されています。

The global wound care market is projected to reach USD 30.48 billion by 2030 from USD 22.22 billion in 2025, at a CAGR of 6.5% during the forecast period.

This is due to the increasing rise of diabetic patients, rising cases of traumatic injuries and burn injuries, and the growing geriatric population, which drives market growth. Additionally, the risk of advanced wound care products restraining the market growth.

The hospitals and clinics segment of the wound care market, by end user, is expected to hold the largest position during the forecast period.

Based on end user, the market is segmented into hospitals and clinics, home care settings, long-term care facilities, and other end users. In 2024, hospitals and clinics account for the largest share of the market. This dominance is driven by the rising prevalence of diabetic foot ulcers and surgical wounds, which require professional medical attention. Additionally, the aging population with chronic conditions such as diabetes and vascular disorders has led to an increase in hospital visits for wound care. Hospitals and specialized care centers are well equipped with experienced medical personnel, standardized treatment protocols, and a comprehensive range of wound care products, enabling efficient and effective treatment. The continued emphasis on enhancing wound care outcomes and patient recovery further reinforces the leading position of this segment.

Asia Pacific is the fastest-growing region of the wound care market.

The global wound care market is segmented into five segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific wound care market is expanding due to a growing aging population and a rise in lifestyle-related diseases that contribute to chronic wounds. Increased demand for quality healthcare and greater investments in hospital infrastructure and medical technologies are boosting the adoption of advanced wound care products. Moreover, the surge in medical tourism across countries like India, Thailand, and Singapore is driving surgical volumes, further increasing the need for post-operative wound care. As healthcare providers in the region focus on improving treatment outcomes and reducing recovery times, the market is poised for robust growth, with Asia Pacific projected to witness the highest CAGR during the forecast period.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
• By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
• By Region: North America: 51%, Europe: 21%, Asia Pacific: 18%, Latin America: 6%, and Middle East & Africa: 4%

Note 1: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the wound care market are Solventum (US), Johnson & Johnson Services, Inc. (US), Smith+ Nephew (UK), Convatec Group PLC (UK), Coloplast Group (Denmark), Cardinal Health (US), Mölnlycke AB (Sweden), Integra LifeSciences Corporation (US), PAUL HARTMANN AG (Germany), B.Braun SE (Germany), Organogenesis Inc. (US), MIMEDX Group, Inc. (US), Essity Aktlebolag (Sweden), Avery Dennison Corporation (US), Mativ Holdings, Inc. (US), Owens & Minor (US), Zimmer Biomet (US), Bioventus (US), Medtronic (Ireland), and Baxter (US).

Research Coverage

This report studies the wound care market based on product, wound type, end user, and country. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.

This report provides insights on the following pointers:

Analysis of key drivers (growing geriatric population, increasing cases of traumatic injuries, growing prevalence of chronic diseases rising incidence of burn injuries, rising use of regenerative medicine for wound management, and government initiatives and reimbursement policies), restraints (high cost of advanced wound care products, risks associated with use of advanced wound care products and antimicrobial resistance challenges), opportunities (Growth opportunities in emerging economies,  technological advancement in wound care, and home-care optimized solutions), challenges (lack of trained healthcare professionals, Limited awareness in underdeveloped regions, and data security and privacy concerns)

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the wound care market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the wound care market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the wound care market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players

Table of Contents

1               INTRODUCTION              40

1.1           STUDY OBJECTIVES       40

1.2           MARKET DEFINITION   41

1.3           STUDY SCOPE   41

1.3.1        MARKET SEGMENTATION AND REGIONAL SCOPE                 41

1.3.2        INCLUSIONS AND EXCLUSIONS 42

1.4           YEARS CONSIDERED      44

1.5           CURRENCY CONSIDERED            44

1.6           STAKEHOLDERS               44

1.7           SUMMARY OF CHANGES               45

2               RESEARCH METHODOLOGY       46

2.1           RESEARCH DATA              46

2.1.1        SECONDARY DATA          47

2.1.1.1    Key data from secondary sources       47

2.1.2        PRIMARY DATA 48

2.1.2.1    Primary sources    48

2.1.2.2    Key industry insights           49

2.1.2.3    Key data from primary sources           49

2.1.2.4    Breakdown of primary interviews      51

2.2           MARKET SIZE ESTIMATION         51

2.2.1        BOTTOM-UP APPROACH              52

2.2.1.1    Approach 1: Company revenue estimation approach     52

2.2.1.2    Approach 2: Presentations of companies          52

2.2.1.3    Approach 3: Primary interviews         52

2.2.1.4    Growth forecast    53

2.2.1.5    CAGR projections                 53

2.2.2        TOP-DOWN APPROACH                53

2.3           MARKET BREAKDOWN AND DATA TRIANGULATION                 54

2.4           RESEARCH ASSUMPTIONS           55

2.4.1        STUDY-RELATED ASSUMPTIONS              55

2.4.2        ASSUMPTIONS, BY PARAMETER                56

2.4.3        GROWTH RATE ASSUMPTIONS 56

2.5           RESEARCH LIMITATIONS             56

2.6           RISK ASSESSMENT           57

3               EXECUTIVE SUMMARY  58

4               PREMIUM INSIGHTS       62

4.1           WOUND CARE MARKET OVERVIEW         62

4.2           ASIA PACIFIC: WOUND CARE MARKET SHARE, BY END USER AND COUNTRY     63

4.3           WOUND CARE MARKET, BY KEY COUNTRY          64

4.4           WOUND CARE MARKET: REGIONAL MIX, 2023–2030                 64

5               MARKET OVERVIEW       65

5.1           INTRODUCTION              65

5.2           MARKET DYNAMICS       65

5.2.1        DRIVERS               66

5.2.1.1    Growing geriatric population              66

5.2.1.2    Rise in cases of traumatic injuries      67

5.2.1.3    Growing prevalence of chronic diseases           67

5.2.1.4    Rising incidence of burn injuries       68

5.2.1.5    Rising use of regenerative medicines for wound management                 69

5.2.1.6    Government initiatives and reimbursement policies      69

5.2.2        RESTRAINTS      70

5.2.2.1    High cost of advanced wound care products    70

5.2.2.2    Risks associated with advanced wound care products    71

5.2.2.3    Antimicrobial resistance challenges  71

5.2.3        OPPORTUNITIES              72

5.2.3.1    Growth opportunities in emerging economies 72

5.2.3.2    Technological advancements in wound care    72

5.2.3.3    Home care-optimized solutions         73

5.2.4        CHALLENGES    73

5.2.4.1    Lack of trained healthcare professionals           73

5.2.4.2    Limited access to wound care solutions in underdeveloped regions   74

5.2.4.3    Data security and privacy concerns   74

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            74

5.4           PRICING ANALYSIS          75

5.4.1        AVERAGE SELLING PRICE TREND, BY PRODUCT                 75

5.4.2        AVERAGE SELLING PRICE TREND OF WOUND CARE PRODUCTS FOR KEY WOUND TYPES, BY KEY PLAYER    76

5.4.3        AVERAGE SELLING PRICE TREND, BY REGION   77

5.5           VALUE CHAIN ANALYSIS               77

5.6           SUPPLY CHAIN ANALYSIS             79

5.7           ECOSYSTEM ANALYSIS  80

5.8           INVESTMENT & FUNDING SCENARIO     81

5.9           TECHNOLOGY ANALYSIS             82

5.9.1        KEY TECHNOLOGIES     82

5.9.1.1    Negative pressure wound therapy      82

5.9.2        COMPLEMENTARY TECHNOLOGIES       82

5.9.2.1    Micropore particle technology            82

5.9.3        ADJACENT TECHNOLOGIES       83

5.9.3.1    Telemedicine and Mobile Health (MHealth)  83

5.10         PATENT ANALYSIS          83

5.11         TRADE ANALYSIS             85

5.11.1      IMPORT SCENARIO         85

5.11.2      EXPORT SCENARIO         86

5.12         KEY CONFERENCES AND EVENTS, 2025–2026        86

5.13         CASE STUDY ANALYSIS 87

5.13.1      CASE STUDY 1: ADOPTION OF ADVANCED WOUND CARE MEASURES

FOR COMPLEX WOUND HEALING            87

5.13.2      CASE STUDY 2: EVALUATION OF NEW HYDROCOLL HYDROCOLLOID DRESSING IN WOUND CARE   88

5.13.3      CASE STUDY 3: SUPPORTED SELF-MANAGEMENT OF HARD-TO-HEAL PRESSURE ULCERS USING SIMPLE 3-STEP FRAMEWORK DEVELOPED

BY COLOPLAST 89

5.14         REGULATORY LANDSCAPE         89

5.14.1      REGULATORY ANALYSIS               89

5.14.1.1  North America      89

5.14.1.1.1                US           89

5.14.1.1.2                Canada   89

5.14.1.2  Europe   90

5.14.1.2.1                Germany                 90

5.14.1.2.2                UK          90

5.14.1.2.3                France    90

5.14.1.3  Asia Pacific            91

5.14.1.3.1                China      91

5.14.1.3.2                Japan      91

5.14.1.3.3                India       91

5.14.1.4  Latin America       92

5.14.1.5  Middle East           92

5.14.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             92

5.14.2.1  North America      92

5.14.2.2  Europe   93

5.14.2.3  Asia Pacific            93

5.14.2.4  Latin America       94

5.14.2.5  Rest of the World 94

5.15         PORTER’S FIVE FORCES ANALYSIS           95

5.15.1      BARGAINING POWER OF SUPPLIERS       96

5.15.2      BARGAINING POWER OF BUYERS             96

5.15.3      THREAT FROM NEW ENTRANTS                96

5.15.4      THREAT FROM SUBSTITUTES   96

5.15.5      INTENSITY OF COMPETITIVE RIVALRY 96

5.16         KEY STAKEHOLDERS AND BUYING CRITERIA     96

5.16.1      KEY STAKEHOLDERS IN BUYING PROCESS           97

5.16.2      BUYING CRITERIA           97

5.17         IMPACT OF AI ON WOUND CARE MARKET           98

5.17.1      INTRODUCTION              98

5.17.2      MARKET POTENTIAL OF AI IN WOUND CARE MARKET                 98

5.17.3      IMPACT OF AI ON WOUND CARE MARKET: USE CASES                 99

5.17.4      KEY COMPANIES IMPLEMENTING AI      99

5.17.5      FUTURE OF AI IN WOUND CARE MARKET             100

5.18         US 2025 TARIFF 100

5.18.1      INTRODUCTION              100

5.18.2      KEY TARIFF RATES          101

5.18.3      PRICE IMPACT ANALYSIS             101

5.18.4      IMPACT ON COUNTRY/REGION                102

5.18.4.1  North America      102

5.18.4.2  Europe   102

5.18.4.3  Asia Pacific            102

5.18.5      IMPACT ON END-USE INDUSTRIES          103

5.18.5.1  Hospitals and clinics            103

6               WOUND CARE MARKET, BY PRODUCT  104

6.1           INTRODUCTION              105

6.2           ADVANCED WOUND CARE PRODUCTS 105

6.2.1        ADVANCED WOUND DRESSINGS, BY TYPE           108

6.2.1.1    Foam dressings     110

6.2.1.1.1 Silicone dressings 114

6.2.1.1.1.1              Ability of silicone dressings to expedite wound closure and reduce risk of maceration to drive market 114

6.2.1.1.2 Non-silicone dressings        117

6.2.1.1.2.1              Non-silicone dressings are designed for patient comfort and ease of use      117

6.2.1.2    Hydrocolloid dressings        119

6.2.1.2.1 Ability of hydrocolloid dressings to promote granulation and formation of new tissues in open wounds to boost demand           119

6.2.1.3    Film dressings       122

6.2.1.3.1 Film dressings offer strong adhesive properties and adaptability to various wound types        122

6.2.1.4    Alginate dressings                 125

6.2.1.4.1 Growing incidence of pressure and diabetic foot ulcers

to fuel growth        125

6.2.1.5    Hydrogel dressings               128

6.2.1.5.1 Ability of hydrogel dressings to provide relief and cooling effect on skin to drive market        128

6.2.1.6    Collagen dressings                130

6.2.1.6.1 Favorable reimbursement scenario for collagen dressings

to support market 130

6.2.1.7    Hydrofiber dressings            133

6.2.1.7.1 Combination of properties of hydrocolloids and alginates

to boost adoption of hydrofiber dressings        133

6.2.1.8    Wound contact layers           136

6.2.1.8.1 Ability of wound contact layers to protect wound beds from bacterial and fungal growth to drive market    136

6.2.1.9    Superabsorbent dressings   138

6.2.1.9.1 Use of superabsorbent dressings for fragile skin to

promote growth    138

6.2.1.10  Other advanced wound care dressings              141

6.2.2        ADVANCED WOUND DRESSINGS, BY PROPERTY                 145

6.2.2.1    Non-antimicrobial dressings               145

6.2.2.1.1 Need for cost-effective dressing alternatives to drive market                 145

6.2.2.2    Antimicrobial dressings       147

6.2.2.2.1 Advanced antimicrobial dressings are designed to prevent or manage infections in wounds              147

6.2.3        DEVICES & ACCESSORIES             149

6.2.3.1    NPWT devices & accessories              152

6.2.3.1.1 Growing adoption of single-use NPWT devices in home

care to drive growth              152

6.2.3.2    Debridement devices & accessories  155

6.2.3.2.1 Focus on developing novel technologies to support market                 155

6.2.3.3    Wound assessment & monitoring devices        158

6.2.3.3.1 Potential cost-reducing capabilities of wound assessment & monitoring devices to boost adoption                158

6.2.3.4    Other devices & accessories                161

6.2.4        BIOLOGICAL SKIN SUBSTITUTES             164

6.2.4.1    Human donor tissue-derived products              167

6.2.4.1.1 High efficacy of human donor tissue-derived products

to support market demand  167

6.2.4.2    Acellular animal-derived products     170

6.2.4.2.1 Recognition of importance of ECM in wound treatment to lead to development of acellular wound care biologics           170

6.2.4.3    Biosynthetic products          172

6.2.4.3.1 Increased bioburden of infected wounds to lead to development of biosynthetic wound care products 172

6.2.5        TOPICAL AGENTS            175

6.2.5.1    Cost-effectiveness and ease of use of topical agents in home care settings to drive demand     175

6.3           SURGICAL WOUND CARE PRODUCTS    178

6.3.1        SUTURES             180

6.3.1.1    High tensile strength of sutures to drive market              180

6.3.2        TISSUE ADHESIVES, SEALANTS, AND GLUES       183

6.3.2.1    Fibrin-based sealants           186

6.3.2.1.1 Fibrin-based sealants replicate final stages of body’s natural blood-clotting process         186

6.3.2.2    Synthetic adhesives              189

6.3.2.2.1 Synthetic adhesives have additional sealing properties

than traditional staples        189

6.3.2.3    Collagen-based sealants      191

6.3.2.3.1 Collagen-based sealants are primarily used in surgical procedures to support hemostasis          191

6.3.3        STAPLERS            194

6.3.3.1    Staple lines are consistent and less likely to leak blood or air                 194

6.4           TRADITIONAL WOUND CARE PRODUCTS            196

6.4.1        FIXATIONS          199

6.4.1.1    Fixation materials ensure dressings, wound pads, and compresses stay securely in place            199

6.4.2        BANDAGES         201

6.4.2.1    Wide usage of bandages to support market growth         201

6.4.3        GAUZES                204

6.4.3.1    Wide usage of gauzes in surgeries and wound packing to propel market growth       204

6.4.4        FIRST AID PLASTERS      206

6.4.4.1    Need for rapid wound management and protection to propel adoption 206

6.4.5        ABSORBENT PADS           209

6.4.5.1    Wide usage of absorbent pads in wound dressing and exudate management to drive market              209

6.4.6        COMPRESSIONS                212

6.4.6.1    Ability of compression products to reduce swelling to boost demand  212

6.4.7        ISLAND DRESSINGS        214

6.4.7.1    Waterproof, antimicrobial, and absorbent properties of island dressings to drive their demand         214

6.4.8        OTHER TRADITIONAL WOUND CARE PRODUCTS                 216

7               WOUND CARE MARKET, BY WOUND TYPE           220

7.1           INTRODUCTION              221

7.2           CHRONIC WOUNDS        221

7.2.1        DIABETIC FOOT ULCERS              224

7.2.1.1    Rising incidence of diabetes to drive market growth      224

7.2.2        PRESSURE ULCERS          228

7.2.2.1    Growing geriatric population to drive market growth    228

7.2.3        VENOUS LEG ULCERS    230

7.2.3.1    Rising prevalence of obesity to drive market growth      230

7.2.4        OTHER CHRONIC WOUNDS        233

7.3           ACUTE WOUNDS              236

7.3.1        SURGICAL & TRAUMATIC WOUNDS        238

7.3.1.1    Rising volume of surgical procedures to drive market    238

7.3.2        BURNS  241

7.3.2.1    High incidence of burn injuries in developing regions to support market growth       241

8               WOUND CARE MARKET, BY END USER   245

8.1           INTRODUCTION              246

8.2           HOSPITALS & CLINICS   246

8.2.1        INPATIENT SETTINGS   250

8.2.1.1    Increasing hospital admissions due to HAIs to drive market                 250

8.2.2        OUTPATIENT SETTINGS               253

8.2.2.1    Rising cost of inpatient facilities to spur market for outpatient

care settings           253

8.3           HOME CARE SETTINGS 255

8.3.1        DECREASED COSTS AND HIGH CONVENIENCE AND COMFORT OF

HOME CARE SETTINGS TO ENSURE MARKET GROWTH 255

8.4           LONG-TERM CARE FACILITIES  258

8.4.1        GROWING GERIATRIC POPULATION TO BOOST NEED FOR BETTER

LONG-TERM CARE          258

8.5           OTHER END USERS         260

9               WOUND CARE MARKET, BY REGION       264

9.1           INTRODUCTION              265

9.2           NORTH AMERICA             265

9.2.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 266

9.2.2        US           274

9.2.2.1    Rising prevalence of diabetes and supportive reimbursement

policies to drive growth       274

9.2.3        CANADA               275

9.2.3.1    Government-backed efforts to support market development                 275

9.3           EUROPE               277

9.3.1        MACROECONOMIC OUTLOOK FOR EUROPE      277

9.3.2        GERMANY           284

9.3.2.1    Rising cases of diabetes and chronic wound burden to boost market    284

9.3.3        FRANCE                285

9.3.3.1    Rising chronic wound cases to drive market expansion  285

9.3.4        UK          286

9.3.4.1    Increase in R&D activity to propel market growth          286

9.3.5        ITALY    288

9.3.5.1    Increased healthcare funding and sustained demand for treatment solutions to drive market  288

9.3.6        SPAIN    289

9.3.6.1    Rising life expectancy and aging population to boost adoption

of wound care products       289

9.3.7        RUSSIA 290

9.3.7.1    Government initiatives to raise awareness about diabetes to

support market expansion   290

9.3.8        REST OF EUROPE             292

9.4           ASIA PACIFIC     293

9.4.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 294

9.4.2        CHINA  302

9.4.2.1    Increasing incidence of diabetic foot ulcers (DFUs) to

encourage growth 302

9.4.3        JAPAN   303

9.4.3.1    Evolving healthcare delivery and infrastructure landscape

to fuel market        303

9.4.4        INDIA    305

9.4.4.1    Booming medical tourism to speed up growth 305

9.4.5        AUSTRALIA         306

9.4.5.1    Growth of medical manufacturing companies to drive market                 306

9.4.6        SOUTH KOREA  308

9.4.6.1    Increasing healthcare spending to sustain growth           308

9.4.7        SINGAPORE        309

9.4.7.1    Increasing focus on wound care therapies to facilitate growth                 309

9.4.8        REST OF ASIA PACIFIC   311

9.5           LATIN AMERICA                312

9.5.1        MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 313

9.5.2        BRAZIL 320

9.5.2.1    Growth in healthcare sector to drive market    320

9.5.3        MEXICO                321

9.5.3.1    Expanding hospital infrastructure to aid growth              321

9.5.4        REST OF LATIN AMERICA             323

9.6           MIDDLE EAST & AFRICA                324

9.6.1        GROWING DEMAND FOR HEALTHCARE FACILITIES TO DRIVE MARKET 324

9.6.2        MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 325

10            COMPETITIVE LANDSCAPE         332

10.1         OVERVIEW          332

10.2         KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024 332

10.2.1      OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN WOUND CARE MARKET 332

10.3         REVENUE ANALYSIS, 2022–2024  333

10.4         MARKET SHARE ANALYSIS, 2024                 334

10.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 338

10.5.1      STARS   339

10.5.2      EMERGING LEADERS     339

10.5.3      PERVASIVE PLAYERS      339

10.5.4      PARTICIPANTS 339

10.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         341

10.5.5.1  Company footprint               341

10.5.5.2  Region footprint   342

10.5.5.3  Product footprint  343

10.5.5.4  Wound type footprint           344

10.5.5.5  End user footprint                 345

10.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        346

10.6.1      PROGRESSIVE COMPANIES         346

10.6.2      RESPONSIVE COMPANIES            346

10.6.3      DYNAMIC COMPANIES  346

10.6.4      STARTING BLOCKS         346

10.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 348

10.6.5.1  Detailed list of key startups/SMEs    348

10.6.5.2  Competitive benchmarking of key startups/SMEs          349

10.7         COMPANY VALUATION AND FINANCIAL METRICS                 349

10.7.1      COMPANY VALUATION 349

10.7.2      FINANCIAL METRICS      350

10.8         BRAND/PRODUCT COMPARISON             351

10.9         COMPETITIVE SCENARIO             352

10.9.1      PRODUCT LAUNCHES & APPROVALS     352

10.9.2      DEALS  353

10.9.3      EXPANSIONS     354

10.9.4      OTHER DEVELOPMENTS              355

11            COMPANY PROFILES      356

11.1         KEY PLAYERS     356

11.1.1      SOLVENTUM     356

11.1.1.1  Business overview 356

11.1.1.2  Products offered   357

11.1.1.3  Recent developments           361

11.1.1.3.1                Product launches & approvals            361

11.1.1.3.2                Other developments             361

11.1.1.4  MnM view              361

11.1.1.4.1                Right to win           361

11.1.1.4.2                Strategic choices   362

11.1.1.4.3                Weaknesses & competitive threats     362

11.1.2      JOHNSON & JOHNSON SERVICES, INC. (ETHICON)                 363

11.1.2.1  Business overview 363

11.1.2.2  Products offered   364

11.1.2.3  Recent developments           365

11.1.2.3.1                Product launches & approvals            365

11.1.2.4  MnM view              365

11.1.2.4.1                Right to win           365

11.1.2.4.2                Strategic choices   365

11.1.2.4.3                Weaknesses & competitive threats     366

11.1.3      SMITH+NEPHEW              367

11.1.3.1  Business overview 367

11.1.3.2  Products offered   368

11.1.3.3  Recent developments           371

11.1.3.3.1                Product launches & approvals            371

11.1.3.3.2                Deals      371

11.1.3.3.3                Expansions             372

11.1.3.3.4                Other developments             372

11.1.3.4  MnM view              373

11.1.3.4.1                Right to win           373

11.1.3.4.2                Strategic choices   373

11.1.3.4.3                Weaknesses & competitive threats     373

11.1.4      CARDINAL HEALTH        374

11.1.4.1  Business overview 374

11.1.4.2  Products offered   375

11.1.4.3  Recent developments           379

11.1.4.3.1                Deals      379

11.1.4.3.2                Expansions             379

11.1.4.4  MnM view              380

11.1.4.4.1                Right to win           380

11.1.4.4.2                Strategic choices   380

11.1.4.4.3                Weaknesses & competitive threats     381

11.1.5      MÖLNLYCKE AB               382

11.1.5.1  Business overview 382

11.1.5.2  Products offered   383

11.1.5.3  Recent developments           386

11.1.5.3.1                Deals      386

11.1.5.3.2                Other developments             387

11.1.5.4  MnM view              387

11.1.5.4.1                Right to win           387

11.1.5.4.2                Strategic choices   387

11.1.5.4.3                Weaknesses & competitive threats     387

11.1.6      CONVATEC GROUP PLC                388

11.1.6.1  Business overview 388

11.1.6.2  Products offered   389

11.1.6.3  Recent developments           390

11.1.6.3.1                Product launches & approvals            390

11.1.6.3.2                Deals      391

11.1.7      COLOPLAST GROUP       392

11.1.7.1  Business overview 392

11.1.7.2  Products offered   393

11.1.7.3  Recent developments           395

11.1.7.3.1                Product launches & approvals            395

11.1.7.3.2                Deals      395

11.1.8      ORGANOGENESIS INC.  396

11.1.8.1  Business overview 396

11.1.8.2  Products offered   397

11.1.8.3  Recent developments           397

11.1.8.3.1                Product launches & approvals            397

11.1.8.3.2                Expansions             397

11.1.9      PAUL HARTMANN AG    398

11.1.9.1  Business overview 398

11.1.9.2  Products offered   399

11.1.9.3  Recent developments           402

11.1.9.3.1                Deals      402

11.1.10   MIMEDX GROUP, INC.   403

11.1.10.1                 Business overview 403

11.1.10.2                 Products offered   404

11.1.10.3                 Recent developments           404

11.1.10.3.1             Product launches & approvals            404

11.1.11   OWENS & MINOR              405

11.1.11.1                 Business overview 405

11.1.11.2                 Products offered   406

11.1.11.3                 Recent developments           408

11.1.11.3.1             Deals      408

11.1.11.3.2             Other developments             408

11.1.12   B. BRAUN SE       409

11.1.12.1                 Business overview 409

11.1.12.2                 Products offered   410

11.1.12.3                 Recent developments           412

11.1.12.3.1             Expansions             412

11.1.12.3.2             Other developments             412

11.1.13   ESSITY AKTIEBOLAG      413

11.1.13.1                 Business overview 413

11.1.13.2                 Products offered   414

11.1.13.3                 Recent developments           417

11.1.13.3.1             Other developments             417

11.1.14   INTEGRA LIFESCIENCES CORPORATION               418

11.1.14.1                 Business overview 418

11.1.14.2                 Products offered   419

11.1.14.3                 Recent developments           420

11.1.14.3.1             Product launches & approvals            420

11.1.14.3.2             Other developments             421

11.1.15   AVERY DENNISON CORPORATION           422

11.1.15.1                 Business overview 422

11.1.15.2                 Products offered   423

11.1.15.3                 Recent developments           424

11.1.15.3.1             Expansions             424

11.1.16   MATIV HOLDINGS, INC.                425

11.1.16.1                 Business overview 425

11.1.16.2                 Products offered   426

11.1.16.3                 Recent developments           427

11.1.16.3.1             Deals      427

11.1.17   BIOVENTUS       428

11.1.17.1                 Business overview 428

11.1.17.2                 Products offered   429

11.1.17.3                 Recent developments           430

11.1.17.3.1             Deals      430

11.1.17.3.2             Other developments             430

11.1.18   ZIMMER BIOMET             431

11.1.18.1                 Business overview 431

11.1.18.2                 Products offered   432

11.1.18.3                 Recent developments           433

11.1.18.3.1             Deals      433

11.1.19   MEDTRONIC      434

11.1.19.1                 Business overview 434

11.1.19.2                 Products offered   436

11.1.20   BAXTER                437

11.1.20.1                 Business overview 437

11.1.20.2                 Products offered   438

11.1.20.3                 Recent developments           439

11.1.20.3.1             Product launches & approvals            439

11.2         OTHER PLAYERS              440

11.2.1      LOHMANN & RAUSCHER GMBH & CO. KG             440

11.2.2      MEDLINE INDUSTRIES, LP           441

11.2.3      DEROYAL INDUSTRIES, INC.       442

11.2.4      WINNER MEDICAL CO., LTD.      443

11.2.5      ADVANCIS (UK)                 444

11.2.6      MIL LABORATORIES PVT. LTD. 445

11.2.7      PENSAR MEDICAL            446

11.2.8      HAROMED BV   447

11.2.9      URGO GROUP   448

11.2.10   DIRECT HEALTHCARE GROUP  449

12            APPENDIX           450

12.1         DISCUSSION GUIDE        450

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                453

12.3         CUSTOMIZATION OPTIONS        455

12.4         RELATED REPORTS         455

12.5         AUTHOR DETAILS           456

LIST OF TABLES

TABLE 1                WOUND CARE MARKET: INCLUSIONS AND EXCLUSIONS      42

TABLE 2                WOUND CARE MARKET: RISK ASSESSMENT                 57

TABLE 3                POPULATION SHARE OF PEOPLE AGED 65 AND ABOVE (% OF TOTAL POPULATION), BY COUNTRY, 2023                 66

TABLE 4                ROAD ACCIDENT DEMOGRAPHICS, 2022                 67

TABLE 5                CHINA: STATE OF PATIENTS (WITH TYPE 2 DFU) ON DISCHARGE, BY AGE

GROUP, JANUARY 2017–DECEMBER 2023                68

TABLE 6                RISKS ASSOCIATED WITH ADVANCED WOUND CARE DEVICES  71

TABLE 7                STRATEGIC DEVELOPMENTS IN ASIA PACIFIC, 2023–2024              72

TABLE 8                AVERAGE SELLING PRICING TREND OF WOUND CARE PRODUCTS, 2023–2025        76

TABLE 9                AVERAGE SELLING PRICE TREND OF WOUND CARE PRODUCTS FOR KEY

WOUND TYPES, BY KEY PLAYER, 2023–2025           76

TABLE 10              AVERAGE SELLING PRICE TREND OF WOUND CARE PRODUCTS,

BY REGION, 2023–2025    77

TABLE 11              WOUND CARE MARKET: ROLE OF PLAYERS IN ECOSYSTEM       81

TABLE 12              WOUND CARE MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023–2025       84

TABLE 13              IMPORT DATA FOR HS CODE 300510-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION)            85

TABLE 14              EXPORT DATA FOR HS CODE 300510-COMPLIANT PRODUCTS,

BY COUNTRY, 2020–2024 (USD MILLION)               86

TABLE 15              WOUND CARE MARKET: KEY CONFERENCES AND EVENTS, APRIL

2025–DECEMBER 2026     86

TABLE 16              TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN         91

TABLE 17              NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  92

TABLE 18              EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND

OTHER ORGANIZATIONS             93

TABLE 19              ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  93

TABLE 20              LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  94

TABLE 21              REST OF THE WORLD: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  94

TABLE 22              IMPACT OF PORTER’S FORCES ON WOUND CARE MARKET  95

TABLE 23              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY KEY PRODUCT (%)               97

TABLE 24              KEY BUYING CRITERIA FOR KEY PRODUCTS                 98

TABLE 25              RECIPROCAL TARIFF RATES ADJUSTED BY US                 101

TABLE 26              WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)       105

TABLE 27             ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            105

TABLE 28             ADVANCED WOUND CARE PRODUCTS MARKET, BY REGION,

2023–2030 (USD MILLION)            106

TABLE 29              NORTH AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 106

TABLE 30              EUROPE: ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)                 106

TABLE 31              ASIA PACIFIC: ADVANCED WOUND CARE PRODUCTS MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            107

TABLE 32              LATIN AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            107

TABLE 33              ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)                108

TABLE 34              ADVANCED WOUND DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)          109

TABLE 35              NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            109

TABLE 36              EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            109

TABLE 37              ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)                 110

TABLE 38              LATIN AMERICA: WOUND CARE DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)                 110

TABLE 39              KEY PRODUCT TYPES IN FOAM DRESSINGS MARKET               111

TABLE 40              FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 112

TABLE 41              FOAM DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)       112

TABLE 42              NORTH AMERICA: FOAM DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            112

TABLE 43              EUROPE: FOAM DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            113

TABLE 44              ASIA PACIFIC: FOAM DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            113

TABLE 45              LATIN AMERICA: FOAM DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            114

TABLE 46              SILICONE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)            114

TABLE 47              NORTH AMERICA: SILICONE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            115

TABLE 48              EUROPE: SILICONE DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            115

TABLE 49              ASIA PACIFIC: SILICONE DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            116

TABLE 50             LATIN AMERICA: SILICONE DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            116

TABLE 51              NON-SILICONE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)          117

TABLE 52              NORTH AMERICA: NON-SILICONE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            117

TABLE 53              EUROPE: NON-SILICONE DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            118

TABLE 54              ASIA PACIFIC: NON-SILICONE DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            118

TABLE 55              LATIN AMERICA: NON-SILICONE DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)                 119

TABLE 56              KEY PRODUCT TYPES IN HYDROCOLLOID DRESSINGS MARKET, BY COMPANY        119

TABLE 57              HYDROCOLLOID DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)          120

TABLE 58              NORTH AMERICA: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            120

TABLE 59             EUROPE: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            121

TABLE 60              ASIA PACIFIC: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            121

TABLE 61              LATIN AMERICA: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          122

TABLE 62              KEY PRODUCT TYPES IN FILM DRESSINGS MARKET, BY COMPANY 122

TABLE 63              FILM DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)       123

TABLE 64              NORTH AMERICA: FILM DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            123

TABLE 65              EUROPE: FILM DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            124

TABLE 66              ASIA PACIFIC: FILM DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            124

TABLE 67              LATIN AMERICA: FILM DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            125

TABLE 68              KEY PRODUCT TYPES IN ALGINATE DRESSINGS MARKET, BY COMPANY 126

TABLE 69              ALGINATE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)            126

TABLE 70              NORTH AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            126

TABLE 71              EUROPE: ALGINATE DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            127

TABLE 72              ASIA PACIFIC: ALGINATE DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            127

TABLE 73              LATIN AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            128

TABLE 74              KEY PRODUCT TYPES IN HYDROGEL DRESSINGS MARKET, BY COMPANY        128

TABLE 75              HYDROGEL DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)            129

TABLE 76              NORTH AMERICA: HYDROGEL DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            129

TABLE 77              EUROPE: HYDROGEL DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            129

TABLE 78              ASIA PACIFIC: HYDROGEL DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            130

TABLE 79              LATIN AMERICA: HYDROGEL DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            130

TABLE 80              KEY PRODUCT TYPES IN COLLAGEN DRESSINGS MARKET, BY COMPANY        131

TABLE 81              COLLAGEN DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)            131

TABLE 82              NORTH AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            132

TABLE 83              EUROPE: COLLAGEN DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            132

TABLE 84              ASIA PACIFIC: COLLAGEN DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            133

TABLE 85              LATIN AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            133

TABLE 86              KEY PRODUCT TYPES IN HYDROFIBER DRESSINGS MARKET, BY COMPANY        134

TABLE 87              HYDROFIBER DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)            134

TABLE 88              NORTH AMERICA: HYDROFIBER DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            134

TABLE 89              EUROPE: HYDROFIBER DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            135

TABLE 90              ASIA PACIFIC: HYDROFIBER DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            135

TABLE 91              LATIN AMERICA: HYDROFIBER DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            136

TABLE 92              KEY PRODUCT TYPES IN WOUND CONTACT LAYERS MARKET, BY COMPANY                136

TABLE 93              WOUND CONTACT LAYERS MARKET, BY REGION, 2023–2030 (USD MILLION)          137

TABLE 94              NORTH AMERICA: WOUND CONTACT LAYERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            137

TABLE 95              EUROPE: WOUND CONTACT LAYERS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            137

TABLE 96              ASIA PACIFIC: WOUND CONTACT LAYERS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            138

TABLE 97              LATIN AMERICA: WOUND CONTACT LAYERS MARKET, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          138

TABLE 98              KEY PRODUCT TYPES IN SUPERABSORBENT DRESSINGS MARKET, BY COMPANY        139

TABLE 99              SUPERABSORBENT DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)          139

TABLE 100            NORTH AMERICA: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            140

TABLE 101            EUROPE: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            140

TABLE 102            ASIA PACIFIC: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)                 141

TABLE 103            LATIN AMERICA: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)            141

TABLE 104            KEY PRODUCT TYPES IN OTHER ADVANCED WOUND CARE DRESSINGS

MARKET, BY COMPANY 142

TABLE 105            OTHER ADVANCED WOUND CARE DRESSINGS MARKET, BY REGION,

2023–2030 (USD MILLION)            143

TABLE 106            NORTH AMERICA: OTHER ADVANCED WOUND CARE DRESSINGS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               143

TABLE 107            EUROPE: OTHER ADVANCED WOUND CARE DRESSINGS MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            144

TABLE 108            ASIA PACIFIC: OTHER ADVANCED WOUND CARE DRESSINGS MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            144

TABLE 109            LATIN AMERICA: OTHER ADVANCED WOUND CARE DRESSINGS MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            145

TABLE 110            ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY,

2023–2030 (USD MILLION)            145

TABLE 111            NON-ANTIMICROBIAL DRESSINGS MARKET, BY REGION,

2023–2030 (USD MILLION)            146

TABLE 112            NORTH AMERICA: NON-ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 146

TABLE 113            EUROPE: NON-ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)                 146

TABLE 114            ASIA PACIFIC: NON-ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)            147

TABLE 115            LATIN AMERICA: NON-ANTIMICROBIAL DRESSINGS MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            147

TABLE 116            ANTIMICROBIAL DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)          148

TABLE 117            NORTH AMERICA: ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            148

TABLE 118            EUROPE: ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            148

TABLE 119            ASIA PACIFIC: ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            149

TABLE 120            LATIN AMERICA: ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          149

TABLE 121            DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)            150

TABLE 122            DEVICES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION)            150

TABLE 123            NORTH AMERICA: DEVICES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            150

TABLE 124            EUROPE: DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            151

TABLE 125            ASIA PACIFIC: DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            151

TABLE 126            LATIN AMERICA: DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            152

TABLE 127            KEY PRODUCT TYPES IN NPWT DEVICES & ACCESSORIES MARKET, BY COMPANY   152

TABLE 128            NPWT DEVICES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION)          153

TABLE 129            NORTH AMERICA: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            154

TABLE 130            EUROPE: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            154

TABLE 131            ASIA PACIFIC: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          155

TABLE 132            LATIN AMERICA: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          155

TABLE 133            KEY PRODUCT TYPES IN DEBRIDEMENT DEVICES & ACCESSORIES MARKET,

BY COMPANY    156

TABLE 134            DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY REGION,

2023–2030 (USD MILLION)            156

TABLE 135            NORTH AMERICA: DEBRIDEMENT DEVICES & ACCESSORIES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               157

TABLE 136            EUROPE: DEBRIDEMENT DEVICES & ACCESSORIES MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            157

TABLE 137            ASIA PACIFIC: DEBRIDEMENT DEVICES & ACCESSORIES MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            158

TABLE 138            LATIN AMERICA: DEBRIDEMENT DEVICES & ACCESSORIES MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            158

TABLE 139            KEY PRODUCT TYPES IN WOUND ASSESSMENT & MONITORING

DEVICES MARKET, BY COMPANY              159

TABLE 140            WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            159

TABLE 141            NORTH AMERICA: WOUND ASSESSMENT & MONITORING DEVICES

MARKET, BY COUNTRY, 2023–2030 (USD MILLION)           159

TABLE 142            EUROPE: WOUND ASSESSMENT & MONITORING DEVICES MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            160

TABLE 143            ASIA PACIFIC: WOUND ASSESSMENT & MONITORING DEVICES MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            160

TABLE 144            LATIN AMERICA: WOUND ASSESSMENT & MONITORING DEVICES MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            161

TABLE 145            OTHER DEVICES & ACCESSORIES MARKET, BY REGION,

2023–2030 (USD MILLION)            162

TABLE 146            NORTH AMERICA: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            163

TABLE 147            EUROPE: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)                 163

TABLE 148            ASIA PACIFIC: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)                 164

TABLE 149            LATIN AMERICA: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)            164

TABLE 150            KEY PRODUCT TYPES IN BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COMPANY   165

TABLE 151            BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2023–2030 (USD MILLION)                165

TABLE 152            BIOLOGICAL SKIN SUBSTITUTES MARKET, BY REGION, 2023–2030 (USD MILLION)          166

TABLE 153            NORTH AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            166

TABLE 154            EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            166

TABLE 155            ASIA PACIFIC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)                 167

TABLE 156            LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)            167

TABLE 157            KEY PRODUCT TYPES IN HUMAN DONOR TISSUE-DERIVED MARKET, BY COMPANY             168

TABLE 158            HUMAN DONOR TISSUE-DERIVED MARKET, BY REGION,

2023–2030 (USD MILLION)            168

TABLE 159            NORTH AMERICA: HUMAN DONOR TISSUE-DERIVED MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            168

TABLE 160            EUROPE: HUMAN DONOR TISSUE-DERIVED MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            169

TABLE 161            ASIA PACIFIC: HUMAN DONOR TISSUE-DERIVED MARKET, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          169

TABLE 162            LATIN AMERICA: HUMAN DONOR TISSUE-DERIVED MARKET, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          170

TABLE 163            KEY PRODUCT TYPES IN ACELLULAR ANIMAL-DERIVED MARKET, BY COMPANY             170

TABLE 164            ACELLULAR ANIMAL-DERIVED MARKET, BY REGION, 2023–2030 (USD MILLION)          171

TABLE 165            NORTH AMERICA: ACELLULAR ANIMAL-DERIVED MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            171

TABLE 166            EUROPE: ACELLULAR ANIMAL-DERIVED MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            171

TABLE 167            ASIA PACIFIC: ACELLULAR ANIMAL-DERIVED MARKET, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          172

TABLE 168            LATIN AMERICA: ACELLULAR ANIMAL-DERIVED MARKET, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          172

TABLE 169            KEY PRODUCT TYPES IN BIOSYNTHETIC MARKET, BY COMPANY 173

TABLE 170            BIOSYNTHETIC PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)          173

TABLE 171            NORTH AMERICA: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            173

TABLE 172            EUROPE: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            174

TABLE 173            ASIA PACIFIC: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            174

TABLE 174            LATIN AMERICA: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          175

TABLE 175            KEY PRODUCT TYPES IN TOPICAL AGENTS MARKET, BY COMPANY 176

TABLE 176            TOPICAL AGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)       176

TABLE 177            NORTH AMERICA: TOPICAL AGENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            177

TABLE 178            EUROPE: TOPICAL AGENTS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            177

TABLE 179            ASIA PACIFIC: TOPICAL AGENTS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            177

TABLE 180            LATIN AMERICA: TOPICAL AGENTS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            178

TABLE 181            SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            178

TABLE 182            SURGICAL WOUND CARE PRODUCTS MARKET, BY REGION,

2023–2030 (USD MILLION)            179

TABLE 183            NORTH AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               179

TABLE 184            EUROPE: SURGICAL WOUND CARE PRODUCTS MARKET, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          179

TABLE 185            ASIA PACIFIC: SURGICAL WOUND CARE PRODUCTS MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            180

TABLE 186            LATIN AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            180

TABLE 187            KEY PRODUCT TYPES IN SUTURES MARKET, BY COMPANY           181

TABLE 188            SUTURES MARKET, BY REGION, 2023–2030 (USD MILLION)            181

TABLE 189            NORTH AMERICA: SUTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     182

TABLE 190            EUROPE: SUTURES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)  182

TABLE 191            ASIA PACIFIC: SUTURES MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            182

TABLE 192            LATIN AMERICA: SUTURES MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            183

TABLE 193            KEY PRODUCT TYPES IN TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET,

BY COMPANY    183

TABLE 194            TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE,

2023–2030 (USD MILLION)            184

TABLE 195            TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY REGION,

2023–2030 (USD MILLION)            184

TABLE 196            NORTH AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               184

TABLE 197            EUROPE: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            185

TABLE 198            ASIA PACIFIC: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            185

TABLE 199          LATIN AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            186

TABLE 200            FIBRIN-BASED SEALANTS MARKET, BY REGION, 2023–2030 (USD MILLION)            187

TABLE 201            NORTH AMERICA: FIBRIN-BASED SEALANTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            187

TABLE 202            EUROPE: FIBRIN-BASED SEALANTS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            187

TABLE 203            ASIA PACIFIC: FIBRIN-BASED SEALANTS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            188

TABLE 204            LATIN AMERICA: FIBRIN-BASED SEALANTS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            188

TABLE 205            SYNTHETIC ADHESIVES MARKET, BY REGION, 2023–2030 (USD MILLION)            189

TABLE 206            NORTH AMERICA: SYNTHETIC ADHESIVES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            189

TABLE 207            EUROPE: SYNTHETIC ADHESIVES MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            190

TABLE 208            ASIA PACIFIC: SYNTHETIC ADHESIVES MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            190

TABLE 209            LATIN AMERICA: SYNTHETIC ADHESIVES MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            191

TABLE 210            COLLAGEN-BASED SEALANTS MARKET, BY REGION, 2023–2030 (USD MILLION)          191

TABLE 211            NORTH AMERICA: COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            192

TABLE 212            EUROPE: COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            192

TABLE 213            ASIA PACIFIC: COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          193

TABLE 214            LATIN AMERICA: COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          193

TABLE 215            KEY PRODUCT TYPES IN STAPLERS MARKET, BY COMPANY           194

TABLE 216            STAPLERS MARKET, BY REGION, 2023–2030 (USD MILLION)            194

TABLE 217            NORTH AMERICA: STAPLERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     194

TABLE 218            EUROPE: STAPLERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)  195

TABLE 219            ASIA PACIFIC: STAPLERS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            195

TABLE 220            LATIN AMERICA: STAPLERS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            196

TABLE 221            TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            196

TABLE 222            TRADITIONAL WOUND CARE PRODUCTS MARKET, BY REGION,

2023–2030 (USD MILLION)            197

TABLE 223            NORTH AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               197

TABLE 224            EUROPE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          197

TABLE 225            ASIA PACIFIC: TRADITIONAL WOUND CARE PRODUCTS MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            198

TABLE 226            LATIN AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            198

TABLE 227            KEY FIXATIONS OFFERED, BY COMPANY                 199

TABLE 228            FIXATIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 200

TABLE 229            NORTH AMERICA: FIXATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     200

TABLE 230            EUROPE: FIXATIONS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)  200

TABLE 231            ASIA PACIFIC: FIXATIONS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            201

TABLE 232            LATIN AMERICA: FIXATIONS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            201

TABLE 233            KEY BANDAGES OFFERED, BY COMPANY                 202

TABLE 234            BANDAGES MARKET, BY REGION, 2023–2030 (USD MILLION) 202

TABLE 235            NORTH AMERICA: BANDAGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     202

TABLE 236            EUROPE: BANDAGES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)  203

TABLE 237            ASIA PACIFIC: BANDAGES MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            203

TABLE 238            LATIN AMERICA: BANDAGES MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            204

TABLE 239            GAUZES OFFERED, BY COMPANY             204

TABLE 240            GAUZES MARKET, BY REGION, 2023–2030 (USD MILLION)            205

TABLE 241            NORTH AMERICA: GAUZES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     205

TABLE 242            EUROPE: GAUZES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)  205

TABLE 243            ASIA PACIFIC: GAUZES MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            206

TABLE 244            LATIN AMERICA: GAUZES MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            206

TABLE 245            KEY FIRST AID PLASTER PRODUCTS OFFERED, BY COMPANY    207

TABLE 246            FIRST AID PLASTERS MARKET, BY REGION, 2023–2030 (USD MILLION)            207

TABLE 247            NORTH AMERICA: FIRST AID PLASTERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            207

TABLE 248            EUROPE: FIRST AID PLASTERS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            208

TABLE 249            ASIA PACIFIC: FIRST AID PLASTERS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            208

TABLE 250            LATIN AMERICA: FIRST AID PLASTERS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            209

TABLE 251            KEY ABSORBENT PADS OFFERED, BY COMPANY                 209

TABLE 252            ABSORBENT PADS MARKET, BY REGION, 2023–2030 (USD MILLION)       210

TABLE 253            NORTH AMERICA: ABSORBENT PADS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            210

TABLE 254            EUROPE: ABSORBENT PADS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            210

TABLE 255            ASIA PACIFIC: ABSORBENT PADS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            211

TABLE 256            LATIN AMERICA: ABSORBENT PADS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            211

TABLE 257            KEY COMPRESSIONS OFFERED, BY COMPANY                 212

TABLE 258            COMPRESSIONS MARKET, BY REGION, 2023–2030 (USD MILLION)       212

TABLE 259            NORTH AMERICA: COMPRESSIONS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            213

TABLE 260            EUROPE: COMPRESSIONS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            213

TABLE 261            ASIA PACIFIC: COMPRESSIONS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            213

TABLE 262            LATIN AMERICA: COMPRESSIONS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            214

TABLE 263            KEY ISLAND DRESSINGS OFFERED, BY COMPANY           214

TABLE 264            ISLAND DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)       215

TABLE 265            NORTH AMERICA: ISLAND DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            215

TABLE 266            EUROPE: ISLAND DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            215

TABLE 267            ASIA PACIFIC: ISLAND DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            216

TABLE 268            LATIN AMERICA: ISLAND DRESSINGS MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            216

TABLE 269            OTHER TRADITIONAL WOUND CARE PRODUCTS OFFERED, BY COMPANY      217

TABLE 270            OTHER TRADITIONAL WOUND CARE PRODUCTS MARKET, BY REGION,

2023–2030 (USD MILLION)            217

TABLE 271            NORTH AMERICA: OTHER TRADITIONAL WOUND CARE PRODUCTS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               217

TABLE 272            EUROPE: OTHER TRADITIONAL WOUND CARE PRODUCTS MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            218

TABLE 273            ASIA PACIFIC: OTHER TRADITIONAL WOUND CARE PRODUCTS MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            218

TABLE 274            LATIN AMERICA: OTHER TRADITIONAL WOUND CARE PRODUCTS MARKET,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            219

TABLE 275            WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)       221

TABLE 276            WOUND CARE MARKET FOR CHRONIC WOUNDS, BY TYPE,

2023–2030 (USD MILLION)            222

TABLE 277            WOUND CARE MARKET FOR CHRONIC WOUNDS, BY REGION,

2023–2030 (USD MILLION)            222

TABLE 278            NORTH AMERICA: WOUND CARE MARKET FOR CHRONIC WOUNDS,

BY COUNTRY, 2023–2030 (USD MILLION)               222

TABLE 279            EUROPE: WOUND CARE MARKET FOR CHRONIC WOUNDS, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          223

TABLE 280            ASIA PACIFIC: WOUND CARE MARKET FOR CHRONIC WOUNDS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            223

TABLE 281            LATIN AMERICA: WOUND CARE MARKET FOR CHRONIC WOUNDS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            224

TABLE 282            DIABETES-RELATED HEALTHCARE EXPENDITURE, BY TERRITORY,

2024 (USD MILLION)       225

TABLE 283            NUMBER OF ADULT PATIENTS WITH DIABETIC FOOT ULCERS, BY COUNTRY,

2023–2030 (THOUSANDS)              225

TABLE 284            WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY REGION,

2023–2030 (USD MILLION)            226

TABLE 285            NORTH AMERICA: WOUND CARE MARKET FOR DIABETIC FOOT ULCERS,

BY COUNTRY, 2023–2030 (USD MILLION)               226

TABLE 286            EUROPE: WOUND CARE MARKET FOR DIABETIC FOOT ULCERS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            226

TABLE 287            ASIA PACIFIC: WOUND CARE MARKET FOR DIABETIC FOOT ULCERS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            227

TABLE 288            LATIN AMERICA: WOUND CARE MARKET FOR DIABETIC FOOT ULCERS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            227

TABLE 289            WOUND CARE MARKET FOR PRESSURE ULCERS, BY REGION,

2023–2030 (USD MILLION)            228

TABLE 290            NORTH AMERICA: WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)                 229

TABLE 291            EUROPE: WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY/

REGION, 2023–2030 (USD MILLION)          229

TABLE 292            ASIA PACIFIC: WOUND CARE MARKET FOR PRESSURE ULCERS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            230

TABLE 293            LATIN AMERICA: WOUND CARE MARKET FOR PRESSURE ULCERS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            230

TABLE 294            WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY REGION,

2023–2030 (USD MILLION)            231

TABLE 295            NORTH AMERICA: WOUND CARE MARKET FOR VENOUS LEG ULCERS,

BY COUNTRY, 2023–2030 (USD MILLION)               232

TABLE 296            EUROPE: WOUND CARE MARKET FOR VENOUS LEG ULCERS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            232

TABLE 297            ASIA PACIFIC: WOUND CARE MARKET FOR VENOUS LEG ULCERS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            233

TABLE 298            LATIN AMERICA: WOUND CARE MARKET FOR VENOUS LEG ULCERS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            233

TABLE 299            WOUND CARE MARKET FOR OTHER CHRONIC WOUNDS, BY REGION,

2023–2030 (USD MILLION)            234

TABLE 300            NORTH AMERICA: WOUND CARE MARKET FOR OTHER CHRONIC WOUNDS,

BY COUNTRY, 2023–2030 (USD MILLION)               234

TABLE 301            EUROPE: WOUND CARE MARKET FOR OTHER CHRONIC WOUNDS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            234

TABLE 302            ASIA PACIFIC: WOUND CARE MARKET FOR OTHER CHRONIC WOUNDS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            235

TABLE 303            LATIN AMERICA: WOUND CARE MARKET FOR OTHER CHRONIC WOUNDS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            235

TABLE 304            WOUND CARE MARKET FOR ACUTE WOUNDS, BY TYPE,

2023–2030 (USD MILLION)            236

TABLE 305            WOUND CARE MARKET FOR ACUTE WOUNDS, BY REGION,

2023–2030 (USD MILLION)            236

TABLE 306            NORTH AMERICA: WOUND CARE MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)                 237

TABLE 307            EUROPE: WOUND CARE MARKET FOR ACUTE WOUNDS, BY COUNTRY/REGION, 2023–2030 (USD MILLION)                 237

TABLE 308            ASIA PACIFIC: WOUND CARE MARKET FOR ACUTE WOUNDS, BY COUNTRY/REGION, 2023–2030 (USD MILLION)            238

TABLE 309            LATIN AMERICA: WOUND CARE MARKET FOR ACUTE WOUNDS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            238

TABLE 310            WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY REGION, 2023–2030 (USD MILLION)                 240

TABLE 311            NORTH AMERICA: WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 240

TABLE 312            EUROPE: WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            240

TABLE 313            ASIA PACIFIC: WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            241

TABLE 314            LATIN AMERICA: WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY/REGION, 2023–2030 (USD MILLION)            241

TABLE 315          WOUND CARE MARKET FOR BURNS, BY REGION, 2023–2030 (USD MILLION)            242

TABLE 316            NORTH AMERICA: WOUND CARE MARKET FOR BURNS, BY COUNTRY,

2023–2030 (USD MILLION)            243

TABLE 317            EUROPE: WOUND CARE MARKET FOR BURNS, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            243

TABLE 318            ASIA PACIFIC: WOUND CARE MARKET FOR BURNS, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            244

TABLE 319            LATIN AMERICA: WOUND CARE MARKET FOR BURNS, BY COUNTRY/REGION, 2023–2030 (USD MILLION)                 244

TABLE 320            WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)       246

TABLE 321            HOSPITALS PER CAPITA, BY COUNTRY, 2024                 247

TABLE 322            WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY TYPE,

2023–2030 (USD MILLION)            248

TABLE 323            WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY REGION,

2023–2030 (USD MILLION)            248

TABLE 324            NORTH AMERICA: WOUND CARE MARKET FOR HOSPITALS & CLINICS,

BY COUNTRY, 2023–2030 (USD MILLION)               248

TABLE 325            EUROPE: WOUND CARE MARKET FOR HOSPITALS & CLINICS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            249

TABLE 326            ASIA PACIFIC: WOUND CARE MARKET FOR HOSPITALS & CLINICS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            249

TABLE 327            LATIN AMERICA: WOUND CARE MARKET FOR HOSPITALS & CLINICS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            250

TABLE 328            WOUND CARE MARKET FOR INPATIENT SETTINGS, BY REGION,

2023–2030 (USD MILLION)            250

TABLE 329            NORTH AMERICA: WOUND CARE MARKET FOR INPATIENT SETTINGS,

BY COUNTRY, 2023–2030 (USD MILLION)               251

TABLE 330            EUROPE: WOUND CARE MARKET FOR INPATIENT SETTINGS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            251

TABLE 331            ASIA PACIFIC: WOUND CARE MARKET FOR INPATIENT SETTINGS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            252

TABLE 332            LATIN AMERICA: WOUND CARE MARKET FOR INPATIENT SETTINGS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            252

TABLE 333            WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY REGION,

2023–2030 (USD MILLION)            253

TABLE 334            NORTH AMERICA: WOUND CARE MARKET FOR OUTPATIENT SETTINGS,

BY COUNTRY, 2023–2030 (USD MILLION)               253

TABLE 335            EUROPE: WOUND CARE MARKET FOR OUTPATIENT SETTINGS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            254

TABLE 336            ASIA PACIFIC: WOUND CARE MARKET FOR OUTPATIENT SETTINGS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            254

TABLE 337            LATIN AMERICA: WOUND CARE MARKET FOR OUTPATIENT SETTINGS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            255

TABLE 338            WOUND CARE MARKET FOR HOME CARE SETTINGS, BY REGION,

2023–2030 (USD MILLION)            256

TABLE 339            NORTH AMERICA: WOUND CARE MARKET FOR HOME CARE SETTINGS,

BY COUNTRY, 2023–2030 (USD MILLION)               256

TABLE 340            EUROPE: WOUND CARE MARKET FOR HOME CARE SETTINGS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            257

TABLE 341            ASIA PACIFIC: WOUND CARE MARKET FOR HOME CARE SETTINGS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            257

TABLE 342            LATIN AMERICA: WOUND CARE MARKET FOR HOME CARE SETTINGS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            258

TABLE 343            WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY REGION,

2023–2030 (USD MILLION)            259

TABLE 344            NORTH AMERICA: WOUND CARE MARKET FOR LONG-TERM CARE

FACILITIES, BY COUNTRY, 2023–2030 (USD MILLION)      259

TABLE 345            EUROPE: WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            259

TABLE 346            ASIA PACIFIC: WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            260

TABLE 347            LATIN AMERICA: WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            260

TABLE 348          WOUND CARE MARKET FOR OTHER END USERS, BY REGION,

2023–2030 (USD MILLION)            261

TABLE 349            NORTH AMERICA: WOUND CARE MARKET FOR OTHER END USERS,

2023–2030 (USD MILLION)            261

TABLE 350            EUROPE: WOUND CARE MARKET FOR OTHER END USERS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            262

TABLE 351            ASIA PACIFIC: WOUND CARE MARKET FOR OTHER END USERS,

BY COUNTRY/REGION, 2023–2030 (USD MILLION)            262

TABLE 352            LATIN AMERICA: WOUND CARE MARKET FOR OTHER END USERS,

BY COUNTRY/REGION, 2022–2030 (USD MILLION)            263

TABLE 353            WOUND CARE MARKET, BY REGION, 2023–2030 (USD MILLION) 265

TABLE 354            NORTH AMERICA: MACROECONOMIC INDICATORS      266

TABLE 355            NORTH AMERICA: WOUND CARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            267

TABLE 356            NORTH AMERICA: WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            268

TABLE 357            NORTH AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            268

TABLE 358            NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            269

TABLE 359            NORTH AMERICA: FOAM DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            269

TABLE 360            NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY,

2023–2030 (USD MILLION)            270

TABLE 361            NORTH AMERICA: DEVICES & ACCESSORIES MARKET, BY TYPE,

2023–2030 (USD MILLION)            270

TABLE 362            NORTH AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE,

2023–2030 (USD MILLION)            270

TABLE 363            NORTH AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            271

TABLE 364            NORTH AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET,

BY TYPE, 2023–2030 (USD MILLION)       271

TABLE 365            NORTH AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         272

TABLE 366            NORTH AMERICA: WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            272

TABLE 367            NORTH AMERICA: CHRONIC WOUND MARKET, BY TYPE,

2023–2030 (USD MILLION)            272

TABLE 368            NORTH AMERICA: ACUTE WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION)                273

TABLE 369            NORTH AMERICA: WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            273

TABLE 370            NORTH AMERICA: HOSPITALS & CLINICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            273

TABLE 371            US: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)       274

TABLE 372            US: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)            274

TABLE 373            US: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)       275

TABLE 374            ESTIMATED NUMBER OF DIABETICS IN CANADA, 2024 VS. 2034   275

TABLE 375          CANADA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            276

TABLE 376            CANADA: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)                276

TABLE 377            CANADA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)            276

TABLE 378            EUROPE: MACROECONOMIC INDICATORS                 277

TABLE 379            EUROPE: WOUND CARE MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            278

TABLE 380            EUROPE: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            278

TABLE 381            EUROPE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            279

TABLE 382            EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            279

TABLE 383            EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)            280

TABLE 384            EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY,

2023–2030 (USD MILLION)            280

TABLE 385            EUROPE: DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)                280

TABLE 386            EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE,

2023–2030 (USD MILLION)            281

TABLE 387            EUROPE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            281

TABLE 388            EUROPE: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE,

2023–2030 (USD MILLION)            281

TABLE 389            EUROPE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            282

TABLE 390            EUROPE: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)                282

TABLE 391            EUROPE: CHRONIC WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION)            282

TABLE 392            EUROPE: ACUTE WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION)            283

TABLE 393            EUROPE: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)            283

TABLE 394            EUROPE: HOSPITALS & CLINICS MARKET, BY TYPE, 2023–2030 (USD MILLION)                283

TABLE 395            GERMANY: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     284

TABLE 396            GERMANY: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)                284

TABLE 397            GERMANY: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)                285

TABLE 398            FRANCE: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            285

TABLE 399            FRANCE: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)                286

TABLE 400            FRANCE: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)            286

TABLE 401            UK: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            287

TABLE 402            UK: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)            287

TABLE 403            UK: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)       287

TABLE 404            ITALY: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            288

TABLE 405            ITALY: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)                288

TABLE 406            ITALY: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)            289

TABLE 407            SPAIN: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            289

TABLE 408            SPAIN: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)                290

TABLE 409            SPAIN: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)            290

TABLE 410            RUSSIA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            291

TABLE 411            RUSSIA: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)                291

TABLE 412            RUSSIA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)            291

TABLE 413            REST OF EUROPE: WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            292

TABLE 414            REST OF EUROPE: WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            293

TABLE 415            REST OF EUROPE: WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            293

TABLE 416            ASIA PACIFIC: KEY MACROECONOMIC INDICATORS      294

TABLE 417            ASIA PACIFIC: WOUND CARE MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            296

TABLE 418            ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     296

TABLE 419            ASIA PACIFIC: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            296

TABLE 420            ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            297

TABLE 421            ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)                297

TABLE 422            ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY,

2023–2030 (USD MILLION)            298

TABLE 423            ASIA PACIFIC: DEVICES & ACCESSORIES MARKET, BY TYPE,

2023–2030 (USD MILLION)            298

TABLE 424            ASIA PACIFIC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE,

2023–2030 (USD MILLION)            298

TABLE 425            ASIA PACIFIC: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            299

TABLE 426            ASIA PACIFIC: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2023–2030 (USD MILLION)                 299

TABLE 427            ASIA PACIFIC: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            300

TABLE 428            ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            300

TABLE 429            ASIA PACIFIC: CHRONIC WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION)                300

TABLE 430            ASIA PACIFIC: ACUTE WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION)                301

TABLE 431            ASIA PACIFIC: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)                301

TABLE 432            ASIA PACIFIC: HOSPITALS & CLINICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            301

TABLE 433            CHINA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            302

TABLE 434            CHINA: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)                302

TABLE 435            CHINA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)            303

TABLE 436            JAPAN: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            304

TABLE 437            JAPAN: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)                304

TABLE 438            JAPAN: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)            304

TABLE 439            INDIA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            305

TABLE 440            INDIA: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)                306

TABLE 441            INDIA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)            306

TABLE 442            AUSTRALIA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     307

TABLE 443            AUSTRALIA: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)             307

TABLE 444            AUSTRALIA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)                307

TABLE 445            SOUTH KOREA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     308

TABLE 446            SOUTH KOREA: WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            308

TABLE 447            SOUTH KOREA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)                309

TABLE 448            SINGAPORE: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     310

TABLE 449            SINGAPORE: WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            310

TABLE 450            SINGAPORE: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)                310

TABLE 451            REST OF ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            311

TABLE 452            REST OF ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            312

TABLE 453            REST OF ASIA PACIFIC: WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            312

TABLE 454            LATIN AMERICA: KEY MACROECONOMIC INDICATORS      313

TABLE 455            LATIN AMERICA: WOUND CARE MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            313

TABLE 456            LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     314

TABLE 457            LATIN AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            314

TABLE 458            LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            315

TABLE 459            LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)                315

TABLE 460            LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY,

2023–2030 (USD MILLION)            316

TABLE 461            LATIN AMERICA: DEVICES & ACCESSORIES MARKET, BY TYPE,

2023–2030 (USD MILLION)            316

TABLE 462            LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE,

2023–2030 (USD MILLION)            316

TABLE 463            LATIN AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            317

TABLE 464          LATIN AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         317

TABLE 465            LATIN AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         318

TABLE 466            LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            318

TABLE 467            LATIN AMERICA: CHRONIC WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION)         318

TABLE 468            LATIN AMERICA: ACUTE WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION)                319

TABLE 469            LATIN AMERICA: WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            319

TABLE 470            LATIN AMERICA: HOSPITALS & CLINICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            319

TABLE 471            BRAZIL: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            320

TABLE 472            BRAZIL: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)                321

TABLE 473            BRAZIL: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)            321

TABLE 474            MEXICO: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            322

TABLE 475            MEXICO: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)                322

TABLE 476            MEXICO: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)            322

TABLE 477            REST OF LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            323

TABLE 478            REST OF LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            323

TABLE 479            REST OF LATIN AMERICA: WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            324

TABLE 480            MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS              325

TABLE 481            MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            325

TABLE 482            MIDDLE EAST & AFRICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 326

TABLE 483            MIDDLE EAST & AFRICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 326

TABLE 484            MIDDLE EAST & AFRICA: FOAM DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            327

TABLE 485            MIDDLE EAST & AFRICA: ADVANCED WOUND DRESSINGS MARKET,

BY PROPERTY, 2023–2030 (USD MILLION)              327

TABLE 486            MIDDLE EAST & AFRICA: DEVICES & ACCESSORIES MARKET, BY TYPE,

2023–2030 (USD MILLION)            327

TABLE 487            MIDDLE EAST & AFRICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2023–2030 (USD MILLION)                 328

TABLE 488            MIDDLE EAST & AFRICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 328

TABLE 489            MIDDLE EAST & AFRICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         328

TABLE 490            MIDDLE EAST & AFRICA: TRADITIONAL WOUND CARE PRODUCTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         329

TABLE 491            MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            329

TABLE 492            MIDDLE EAST & AFRICA: CHRONIC WOUND MARKET, BY TYPE,

2023–2030 (USD MILLION)            330

TABLE 493            MIDDLE EAST & AFRICA: ACUTE WOUND MARKET, BY TYPE,

2023–2030 (USD MILLION)            330

TABLE 494            MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            330

TABLE 495            MIDDLE EAST & AFRICA: HOSPITALS & CLINICS MARKET, BY TYPE,

2023–2030 (USD MILLION)            331

TABLE 496            OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS,

JANUARY 2022–MAY 2025               332

TABLE 497            WOUND CARE MARKET: DEGREE OF COMPETITION 335

TABLE 498            WOUND CARE MARKET: REGION FOOTPRINT                 342

TABLE 499            WOUND CARE MARKET: PRODUCT FOOTPRINT                 343

TABLE 500            WOUND CARE MARKET: WOUND TYPE FOOTPRINT       344

TABLE 501            WOUND CARE MARKET: END USER FOOTPRINT                 345

TABLE 502            WOUND CARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES              348

TABLE 503            WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES          349

TABLE 504            WOUND CARE MARKET: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–MAY 2025               352

TABLE 505            WOUND CARE MARKET: DEALS, JANUARY 2022–MAY 2025              353

TABLE 506            WOUND CARE MARKET: EXPANSIONS, JANUARY 2022–MAY 2025   354

TABLE 507            WOUND CARE MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025          355

TABLE 508            SOLVENTUM: COMPANY OVERVIEW      356

TABLE 509            SOLVENTUM: PRODUCTS OFFERED       357

TABLE 510            SOLVENTUM: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025    361

TABLE 511            SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025               361

TABLE 512            JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW   363

TABLE 513            JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED    364

TABLE 514            JOHNSON & JOHNSON SERVICES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025                 365

TABLE 515            SMITH+NEPHEW: COMPANY OVERVIEW                 367

TABLE 516            SMITH+NEPHEW: PRODUCTS OFFERED                 368

TABLE 517            SMITH+NEPHEW: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025    371

TABLE 518            SMITH+NEPHEW: DEALS, JANUARY 2022–MAY 2025        371

TABLE 519            SMITH+NEPHEW: EXPANSIONS, JANUARY 2022–MAY 2025              372

TABLE 520            SMITH+NEPHEW: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025               372

TABLE 521            CARDINAL HEALTH: COMPANY OVERVIEW                 374

TABLE 522            CARDINAL HEALTH: PRODUCTS OFFERED                 375

TABLE 523            CARDINAL HEALTH: DEALS, JANUARY 2022–MAY 2025        379

TABLE 524            CARDINAL HEALTH: EXPANSIONS, JANUARY 2022–MAY 2025   379

TABLE 525            MÖLNLYCKE AB: COMPANY OVERVIEW                 382

TABLE 526            MÖLNLYCKE AB: PRODUCTS OFFERED 383

TABLE 527            MÖLNLYCKE AB: DEALS, JANUARY 2022–MAY 2025        386

TABLE 528            MÖLNLYCKE AB: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025               387

TABLE 529            CONVATEC GROUP PLC: COMPANY OVERVIEW                 388

TABLE 530            CONVATEC GROUP PLC: PRODUCTS OFFERED                 389

TABLE 531            CONVATEC GROUP PLC: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–MAY 2025               390

TABLE 532            CONVATEC GROUP PLC: DEALS, JANUARY 2022–MAY 2025              391

TABLE 533            COLOPLAST GROUP: COMPANY OVERVIEW                 392

TABLE 534            COLOPLAST GROUP: PRODUCTS OFFERED                 393

TABLE 535            COLOPLAST GROUP: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–MAY 2025               395

TABLE 536            COLOPLAST GROUP: DEALS, JANUARY 2022–MAY 2025              395

TABLE 537            ORGANOGENESIS INC.: COMPANY OVERVIEW                 396

TABLE 538            ORGANOGENESIS INC.: PRODUCTS OFFERED                 397

TABLE 539            ORGANOGENESIS INC.: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–MAY 2025               397

TABLE 540            ORGANOGENESIS INC.: EXPANSIONS, JANUARY 2022–MAY 2025   397

TABLE 541            PAUL HARTMANN AG: COMPANY OVERVIEW                 398

TABLE 542            PAUL HARTMANN AG: PRODUCTS OFFERED                 399

TABLE 543            PAUL HARTMANN AG: DEALS, JANUARY 2022–MAY 2025              402

TABLE 544            MIMEDX GROUP, INC.: COMPANY OVERVIEW                 403

TABLE 545            MIMEDX GROUP, INC.: PRODUCTS OFFERED                 404

TABLE 546            MIMEDX GROUP, INC.: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–MAY 2025               404

TABLE 547            OWENS & MINOR: COMPANY OVERVIEW                 405

TABLE 548            OWENS & MINOR: PRODUCTS OFFERED                 406

TABLE 549            OWENS & MINOR: DEALS, JANUARY 2022–JANUARY 2025    408

TABLE 550            OWENS & MINOR: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025               408

TABLE 551            B. BRAUN SE: COMPANY OVERVIEW       409

TABLE 552            B. BRAUN SE: PRODUCTS OFFERED        410

TABLE 553            B. BRAUN SE: EXPANSIONS, JANUARY 2022–MAY 2025        412

TABLE 554            B. BRAUN SE: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025               412

TABLE 555            ESSITY AKTIEBOLAG: COMPANY OVERVIEW                 413

TABLE 556            ESSITY AKTIEBOLAG: PRODUCTS OFFERED                 414

TABLE 557            ESSITY AKTLEBOLAG: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025               417

TABLE 558            INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW   418

TABLE 559            INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED    419

TABLE 560            INTEGRA LIFESCIENCES CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025                 420

TABLE 561            INTEGRA LIFESCIENCES CORPORATION: OTHER DEVELOPMENTS,

JANUARY 2022–MAY 2025               421

TABLE 562            AVERY DENNISON CORPORATION: COMPANY OVERVIEW          422

TABLE 563            AVERY DENNISON CORPORATION: PRODUCTS OFFERED             423

TABLE 564            AVERY DENNISON CORPORATION: EXPANSIONS, JANUARY 2022–MAY 2025  424

TABLE 565            MATIV HOLDINGS, INC.: COMPANY OVERVIEW                 425

TABLE 566            MATIV HOLDINGS, INC.: PRODUCTS OFFERED                 426

TABLE 567            MATIV HOLDINGS, INC.: DEALS, JANUARY 2022–MAY 2025              427

TABLE 568            BIOVENTUS: COMPANY OVERVIEW        428

TABLE 569            BIOVENTUS: PRODUCTS OFFERED         429

TABLE 570            BIOVENTUS: DEALS, JANUARY 2022–JANUARY 2025        430

TABLE 571            BIOVENTUS: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025               430

TABLE 572            ZIMMER BIOMET: COMPANY OVERVIEW                 431

TABLE 573            ZIMMER BIOMET: PRODUCTS OFFERED                 432

TABLE 574            ZIMMER BIOMET: DEALS, JANUARY 2022–MAY 2025        433

TABLE 575            MEDTRONIC: COMPANY OVERVIEW       434

TABLE 576            MEDTRONIC: PRODUCTS OFFERED        436

TABLE 577            BAXTER: COMPANY OVERVIEW 437

TABLE 578            BAXTER: PRODUCTS OFFERED 438

TABLE 579            BAXTER: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025               439

TABLE 580            LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW   440

TABLE 581            MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW          441

TABLE 582            DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW          442

TABLE 583            WINNER MEDICAL CO., LTD.: COMPANY OVERVIEW          443

TABLE 584            ADVANCIS (UK): COMPANY OVERVIEW 444

TABLE 585            MIL LABORATORIES PVT. LTD.: COMPANY OVERVIEW          445

TABLE 586            PENSAR MEDICAL: COMPANY OVERVIEW                 446

TABLE 587            HAROMED BV: COMPANY OVERVIEW    447

TABLE 588            URGO GROUP: COMPANY OVERVIEW    448

TABLE 589            DIRECT HEALTHCARE GROUP: COMPANY OVERVIEW          449

LIST OF FIGURES

FIGURE 1              MARKET SEGMENTATION AND REGIONAL SCOPE  41

FIGURE 2              WOUND CARE MARKET: RESEARCH DESIGN                 46

FIGURE 3              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION     51

FIGURE 4              BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH              52

FIGURE 5              CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 53

FIGURE 6              WOUND CARE MARKET: TOP-DOWN APPROACH         53

FIGURE 7              DATA TRIANGULATION METHODOLOGY                 55

FIGURE 8              WOUND CARE MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)       58

FIGURE 9              WOUND CARE MARKET, BY WOUND TYPE, 2025 VS. 2030 (USD MILLION)                59

FIGURE 10            WOUND CARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)       59

FIGURE 11            GEOGRAPHICAL SNAPSHOT OF WOUND CARE MARKET               60

FIGURE 12            INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET GROWTH            62

FIGURE 13            HOSPITALS & CLINICS SEGMENT AND CHINA ACCOUNTED FOR

SIGNIFICANT SHARE IN 2024       63

FIGURE 14            JAPAN TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030          64

FIGURE 15            ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD       64

FIGURE 16            WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          65

FIGURE 17            TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS   75

FIGURE 18            VALUE CHAIN ANALYSIS               78

FIGURE 19            SUPPLY CHAIN ANALYSIS             79

FIGURE 20            ECOSYSTEM ANALYSIS  80

FIGURE 21            INVESTMENT AND FUNDING SCENARIO, 2020–2025 (USD MILLION)       81

FIGURE 22            WOUND CARE MARKET: PATENT ANALYSIS, JANUARY 2015–DECEMBER 2024 83

FIGURE 23            PORTER’S FIVE FORCES ANALYSIS           95

FIGURE 24            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY KEY PRODUCT       97

FIGURE 25            KEY BUYING CRITERIA FOR KEY PRODUCTS                 97

FIGURE 26            IMPACT OF AI ON WOUND CARE MARKET: USE CASES   99

FIGURE 27            NORTH AMERICA: WOUND CARE MARKET SNAPSHOT          267

FIGURE 28            ASIA PACIFIC: WOUND CARE MARKET SNAPSHOT          295

FIGURE 29            REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION) 334

FIGURE 30            MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024        335

FIGURE 31            ADVANCED WOUND CARE PRODUCTS: MARKET SHARE ANALYSIS OF

KEY PLAYERS, 2024           336

FIGURE 32            NEGATIVE PRESSURE WOUND THERAPY (NPWT): MARKET SHARE

ANALYSIS OF KEY PLAYERS, 2024               337

FIGURE 33            ADVANCED WOUND DRESSINGS: MARKET SHARE ANALYSIS OF

KEY PLAYERS, 2024           337

FIGURE 34            TRADITIONAL WOUND CARE PRODUCTS: MARKET SHARE ANALYSIS

OF KEY PLAYERS, 2024   338

FIGURE 35            RANKING OF KEY PLAYERS, 2024               338

FIGURE 36            WOUND CARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024         340

FIGURE 37            WOUND CARE MARKET: COMPANY FOOTPRINT                 341

FIGURE 38            WOUND CARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 347

FIGURE 39            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN, AND 5-YEAR STOCK BETA

OF KEY VENDORS            349

FIGURE 40            EV/EBITDA OF KEY VENDORS   350

FIGURE 41            BRAND/PRODUCT COMPARATIVE ANALYSIS                 351

FIGURE 42            SOLVENTUM: COMPANY SNAPSHOT (2024)                 357

FIGURE 43            JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2024)      364

FIGURE 44            SMITH+NEPHEW: COMPANY SNAPSHOT (2024)                 368

FIGURE 45            CARDINAL HEALTH: COMPANY SNAPSHOT (2024)    375

FIGURE 46            MÖLNLYCKE AB: COMPANY SNAPSHOT (2024)                 383

FIGURE 47            CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024)    389

FIGURE 48            COLOPLAST GROUP: COMPANY SNAPSHOT (2024)    393

FIGURE 49            ORGANOGENESIS INC.: COMPANY SNAPSHOT (2024)    396

FIGURE 50            PAUL HARTMANN AG: COMPANY SNAPSHOT (2024)    399

FIGURE 51            MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2024)    403

FIGURE 52            OWENS & MINOR: COMPANY SNAPSHOT (2024)                 406

FIGURE 53            B. BRAUN SE: COMPANY SNAPSHOT (2024)                 410

FIGURE 54            ESSITY AKTIEBOLAG: COMPANY SNAPSHOT (2024)    414

FIGURE 55            INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2024)      419

FIGURE 56            AVERY DENNISON CORPORATION: COMPANY SNAPSHOT (2024)             423

FIGURE 57            MATIV HOLDINGS, INC.: COMPANY SNAPSHOT (2024)    426

FIGURE 58            BIOVENTUS: COMPANY SNAPSHOT (2024)                 429

FIGURE 59            ZIMMER BIOMET: COMPANY SNAPSHOT (2024)                 432

FIGURE 60            MEDTRONIC: COMPANY SNAPSHOT (2024)                 435

FIGURE 61            BAXTER: COMPANY SNAPSHOT (2024)   438

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧